These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
351 related articles for article (PubMed ID: 30012671)
1. A RIPK3-PGE Yan G; Zhao H; Zhang Q; Zhou Y; Wu L; Lei J; Wang X; Zhang J; Zhang X; Zheng L; Du G; Xiao W; Tang B; Miao H; Li Y Cancer Res; 2018 Oct; 78(19):5586-5599. PubMed ID: 30012671 [TBL] [Abstract][Full Text] [Related]
2. Tumor-Derived Prostaglandin E2 Promotes p50 NF-κB-Dependent Differentiation of Monocytic MDSCs. Porta C; Consonni FM; Morlacchi S; Sangaletti S; Bleve A; Totaro MG; Larghi P; Rimoldi M; Tripodo C; Strauss L; Banfi S; Storto M; Pressiani T; Rimassa L; Tartari S; Ippolito A; Doni A; Soldà G; Duga S; Piccolo V; Ostuni R; Natoli G; Bronte V; Balzac F; Turco E; Hirsch E; Colombo MP; Sica A Cancer Res; 2020 Jul; 80(13):2874-2888. PubMed ID: 32265223 [TBL] [Abstract][Full Text] [Related]
3. Feedback loop between fatty acid transport protein 2 and receptor interacting protein 3 pathways promotes polymorphonuclear neutrophil myeloid-derived suppressor cells-potentiated suppressive immunity in bladder cancer. Shi X; Pang S; Zhou J; Yan G; Sun J; Tan W Mol Biol Rep; 2022 Dec; 49(12):11643-11652. PubMed ID: 36169895 [TBL] [Abstract][Full Text] [Related]
5. EP2 and EP4 blockade prevents tumor-induced suppressive features in human monocytic myeloid-derived suppressor cells. Cuenca-Escalona J; Subtil B; Garcia-Perez A; Cambi A; de Vries IJM; Flórez-Grau G Front Immunol; 2024; 15():1355769. PubMed ID: 38343540 [TBL] [Abstract][Full Text] [Related]
6. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice. Wang D; Fu L; Sun H; Guo L; DuBois RN Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of tumor-derived prostaglandin-e2 blocks the induction of myeloid-derived suppressor cells and recovers natural killer cell activity. Mao Y; Sarhan D; Steven A; Seliger B; Kiessling R; Lundqvist A Clin Cancer Res; 2014 Aug; 20(15):4096-106. PubMed ID: 24907113 [TBL] [Abstract][Full Text] [Related]
8. Bladder-cancer-derived exosomal circRNA_0013936 promotes suppressive immunity by up-regulating fatty acid transporter protein 2 and down-regulating receptor-interacting protein kinase 3 in PMN-MDSCs. Shi X; Pang S; Zhou J; Yan G; Gao R; Wu H; Wang Z; Wei Y; Liu X; Tan W Mol Cancer; 2024 Mar; 23(1):52. PubMed ID: 38461272 [TBL] [Abstract][Full Text] [Related]
9. Small-molecule inhibition of prostaglandin E receptor 2 impairs cyclooxygenase-associated malignant glioma growth. Qiu J; Li Q; Bell KA; Yao X; Du Y; Zhang E; Yu JJ; Yu Y; Shi Z; Jiang J Br J Pharmacol; 2019 Jun; 176(11):1680-1699. PubMed ID: 30761522 [TBL] [Abstract][Full Text] [Related]
10. Autocrine IL6-Mediated Activation of the STAT3-DNMT Axis Silences the TNFα-RIP1 Necroptosis Pathway to Sustain Survival and Accumulation of Myeloid-Derived Suppressor Cells. Smith AD; Lu C; Payne D; Paschall AV; Klement JD; Redd PS; Ibrahim ML; Yang D; Han Q; Liu Z; Shi H; Hartney TJ; Nayak-Kapoor A; Liu K Cancer Res; 2020 Aug; 80(15):3145-3156. PubMed ID: 32554751 [TBL] [Abstract][Full Text] [Related]
11. Prostaglandin E2-EP2-NF-κB signaling in macrophages as a potential therapeutic target for intracranial aneurysms. Aoki T; Frȍsen J; Fukuda M; Bando K; Shioi G; Tsuji K; Ollikainen E; Nozaki K; Laakkonen J; Narumiya S Sci Signal; 2017 Feb; 10(465):. PubMed ID: 28174280 [TBL] [Abstract][Full Text] [Related]
12. Blocking Dectin-1 prevents colorectal tumorigenesis by suppressing prostaglandin E2 production in myeloid-derived suppressor cells and enhancing IL-22 binding protein expression. Tang C; Sun H; Kadoki M; Han W; Ye X; Makusheva Y; Deng J; Feng B; Qiu D; Tan Y; Wang X; Guo Z; Huang C; Peng S; Chen M; Adachi Y; Ohno N; Trombetta S; Iwakura Y Nat Commun; 2023 Mar; 14(1):1493. PubMed ID: 36932082 [TBL] [Abstract][Full Text] [Related]
13. Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells. Obermajer N; Muthuswamy R; Lesnock J; Edwards RP; Kalinski P Blood; 2011 Nov; 118(20):5498-505. PubMed ID: 21972293 [TBL] [Abstract][Full Text] [Related]
14. TFF3 mediates the NF-κB/COX2 pathway to regulate PMN-MDSCs activation and protect against necrotizing enterocolitis. Liu J; Yang Q; Chen Z; Lv S; Tang J; Xing Z; Shi M; Lei A; Xiao G; He Y Eur J Immunol; 2021 May; 51(5):1110-1125. PubMed ID: 33547649 [TBL] [Abstract][Full Text] [Related]
15. Co-administration of sulforaphane and doxorubicin attenuates breast cancer growth by preventing the accumulation of myeloid-derived suppressor cells. Rong Y; Huang L; Yi K; Chen H; Liu S; Zhang W; Yuan C; Song X; Wang F Cancer Lett; 2020 Nov; 493():189-196. PubMed ID: 32891712 [TBL] [Abstract][Full Text] [Related]
17. Prostaglandin E Lian S; Xia Y; Ung TT; Khoi PN; Yoon HJ; Lee SG; Kim KK; Jung YD Mol Carcinog; 2017 Feb; 56(2):664-680. PubMed ID: 27377703 [TBL] [Abstract][Full Text] [Related]
18. The mTOR signal regulates myeloid-derived suppressor cells differentiation and immunosuppressive function in acute kidney injury. Zhang C; Wang S; Li J; Zhang W; Zheng L; Yang C; Zhu T; Rong R Cell Death Dis; 2017 Mar; 8(3):e2695. PubMed ID: 28333137 [TBL] [Abstract][Full Text] [Related]
19. Myeloid-derived suppressor cell function is diminished in aspirin-triggered allergic airway hyperresponsiveness in mice. Shi M; Shi G; Tang J; Kong D; Bao Y; Xiao B; Zuo C; Wang T; Wang Q; Shen Y; Wang H; Funk CD; Zhou J; Yu Y J Allergy Clin Immunol; 2014 Nov; 134(5):1163-74.e16. PubMed ID: 24948368 [TBL] [Abstract][Full Text] [Related]
20. Activated hepatic stellate cells promote liver cancer by induction of myeloid-derived suppressor cells through cyclooxygenase-2. Xu Y; Zhao W; Xu J; Li J; Hong Z; Yin Z; Wang X Oncotarget; 2016 Feb; 7(8):8866-78. PubMed ID: 26758420 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]